109 related articles for article (PubMed ID: 11102684)
1. Biodegradable microparticles as a two-drug controlled release formulation: a potential treatment of inflammatory bowel disease.
Lamprecht A; Rodero Torres H; Schäfer U; Lehr CM
J Control Release; 2000 Dec; 69(3):445-54. PubMed ID: 11102684
[TBL] [Abstract][Full Text] [Related]
2. The preparation and evaluation of poly(epsilon-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug.
Hombreiro Pérez M; Zinutti C; Lamprecht A; Ubrich N; Astier A; Hoffman M; Bodmeier R; Maincent P
J Control Release; 2000 Apr; 65(3):429-38. PubMed ID: 10699300
[TBL] [Abstract][Full Text] [Related]
3. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
Chaw CS; Yang YY; Lim IJ; Phan TT
J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
[TBL] [Abstract][Full Text] [Related]
4. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
Kumar PS; Ramakrishna S; Saini TR; Diwan PV
Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
[TBL] [Abstract][Full Text] [Related]
5. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
6. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
[TBL] [Abstract][Full Text] [Related]
7. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
Witschi C; Doelker E
J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
[TBL] [Abstract][Full Text] [Related]
8. Topical delivery of urea encapsulated in biodegradable PLGA microparticles: O/W and W/O creams.
Haddadi A; Aboofazeli R; Erfan M; Farboud ES
J Microencapsul; 2008 Sep; 25(6):379-86. PubMed ID: 18465299
[TBL] [Abstract][Full Text] [Related]
9. Optimizing formulation factors in preparing chitosan microparticles by spray-drying method.
Huang YC; Chiang CH; Yeh MK
J Microencapsul; 2003; 20(2):247-60. PubMed ID: 12554378
[TBL] [Abstract][Full Text] [Related]
10. Encapsulation of water-soluble drugs by an o/o/o-solvent extraction microencapsulation method.
Elkharraz K; Ahmed AR; Dashevsky A; Bodmeier R
Int J Pharm; 2011 May; 409(1-2):89-95. PubMed ID: 21356287
[TBL] [Abstract][Full Text] [Related]
11. PLA-microparticles formulated by means a thermoreversible gel able to modify protein encapsulation and release without being co-encapsulated.
Leo E; Ruozi B; Tosi G; Vandelli MA
Int J Pharm; 2006 Oct; 323(1-2):131-8. PubMed ID: 16815657
[TBL] [Abstract][Full Text] [Related]
12. Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid).
Frauke Pistel K; Breitenbach A; Zange-Volland R; Kissel T
J Control Release; 2001 May; 73(1):7-20. PubMed ID: 11337055
[TBL] [Abstract][Full Text] [Related]
13. Issues in long-term protein delivery using biodegradable microparticles.
Ye M; Kim S; Park K
J Control Release; 2010 Sep; 146(2):241-60. PubMed ID: 20493221
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical and in vitro mucoadhesive properties of microparticles/discs of betamethasone for the management of oral lichen planus.
Monajjemzadeh F; Gholizadeh N; Yousefzadeh Mobaraki N; Jelvehgari M
Pharm Dev Technol; 2016 Dec; 21(8):996-1005. PubMed ID: 26413792
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of negatively charged poly(lactic-co-glycolic acid) microspheres.
Xu Q; Crossley A; Czernuszka J
J Pharm Sci; 2009 Jul; 98(7):2377-89. PubMed ID: 19009589
[TBL] [Abstract][Full Text] [Related]
16. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
Xu H; Zhong H; Liu M; Xu C; Gao Y
Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
[TBL] [Abstract][Full Text] [Related]
17. Encapsulation and release of the hypnotic agent zolpidem from biodegradable polymer microparticles containing hydroxypropyl-beta-cyclodextrin.
Trapani G; Lopedota A; Boghetich G; Latrofa A; Franco M; Sanna E; Liso G
Int J Pharm; 2003 Dec; 268(1-2):47-57. PubMed ID: 14643976
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of propranolol hydrochloride nanoparticles: a comparative study.
Ubrich N; Bouillot P; Pellerin C; Hoffman M; Maincent P
J Control Release; 2004 Jun; 97(2):291-300. PubMed ID: 15196756
[TBL] [Abstract][Full Text] [Related]
19. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
Choi SH; Park TG
Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
[TBL] [Abstract][Full Text] [Related]
20. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
Desai KG; Mallery SR; Schwendeman SP
Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]